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Abstract
Background: Interval breast cancers are often diagnosed at a more advanced stage than screen-detected cancers.
Our aim was to identify features in screening mammograms of the normal breast that would differentiate between
future interval cancers and screen-detected cancers, and to understand how each feature affects tumor
detectability.
Methods: From a population-based cohort of invasive breast cancer cases in Stockholm-Gotland, Sweden,
diagnosed from 2001 to 2008, we analyzed the contralateral mammogram at the preceding negative screening of
394 interval cancer cases and 1009 screen-detected cancers. We examined 32 different image features in digitized
film mammograms, based on three alternative dense area identification methods, by a set of logistic regression
models adjusted for percent density with interval cancer versus screen-detected cancer as the outcome. Features
were forward-selected into a multiple logistic regression model adjusted for mammographic percent density, age,
BMI and use of hormone replacement therapy. The associations of the identified features were assessed also in a
sample from an independent cohort.
Results: Two image features, ‘skewness of the intensity gradient’ and ‘eccentricity’, were associated with the risk of
interval compared with screen-detected cancer. For the first feature, the per-standard deviation odds ratios were 1.
32 (95 % CI: 1.12 to 1.56) and 1.21 (95 % CI: 1.04 to 1.41) in the primary and validation cohort respectively. For the
second feature, they were 1.20 (95 % CI: 1.04 to 1.39) and 1.17 (95%CI: 0.98 to 1.39) respectively. The first feature
was associated with the tumor size at screen detection, while the second feature was associated with the tumor
size at interval detection.
Conclusions: We identified two novel mammographic features in screening mammograms of the normal breast
that differentiated between future interval cancers and screen-detected cancers. We present a starting point for
further research into features beyond percent density that might be relevant for interval cancer, and suggest ways
to use this information to improve screening.
Keywords: Breast cancer, Interval cancer, Cancer screening, Early detection, Mammography, Computer-assisted
image processing
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Background
Interval cancer (IC) is a cancer that is diagnosed in the
interval between two mammographic screening visits. In
this study, we have defined IC as breast cancer that is
detected after a negative screen, or after a positive screen
with a negative workup, but before the next regular visit
or end of a normal screening interval, whichever came
first. The length of a normal screening interval was be-
tween 18 and 24 months depending on age and county.
IC has been shown to have a more aggressive phenotype
than screen-detected cancer (SC) [1–7]. Several breast
cancer screening strategies have been proposed which
might decrease the IC incidence, such as increasing the
screening frequency [8] or using supplemental imaging
[9] in addition to mammography, e.g., magnetic reson-
ance imaging (MRI) or ultrasound. However, adding
examinations strain scarce medical resources, increase
cost and impose a burden on the women in the screen-
ing program. There is a need to more accurately identify
women at high risk of interval breast cancer and to
understand which strategy would be most adequate for
decreasing the risk of interval cancer by earlier screen
detection.
Until now, the only feature of mammographic images
of the normal breast that has been found to be associ-
ated with IC, compared with SC, is percent mammo-
graphic density (PD), i.e., the percentage of the pixels of
the total breast area that has an intensity above a certain
threshold. The association between high PD and interval
cancer is believed to be related to an increased risk that
dense benign tissue would mask a tumor [1, 7, 10]. If a
woman has a high PD the tumor often needs to be larger
before it can be detected on a screening mammogram
[11, 12]. Previous studies of associations between interval
cancer and image features other than PD have mainly
focused on identifying pre-malignant changes [13, 14].
In the present study we examine a large set of image
features, an approach that is often applied in machine
learning. This feature-based approach has not been used
previously in IC studies of the mammographic image of
the normal breast phenotype. Our aim was to identify
image features, in addition to PD, of preceding negative
screening mammograms that might differentiate be-
tween interval cancers and screen-detected cancers. A
secondary aim was to examine which feature might help
us more accurately select women for whom supplemen-
tal imaging examinations would be most valuable in
order to detect tumors earlier.
Methods
Study population
We analyzed breast cancer cases in the Libro-1 population-
based cohort, which consists of women in the Stockholm-
Gotland region diagnosed with breast cancer from 2001 to
2008. The Libro-1 cohort has been described in detail earl-
ier [7, 15]. All women were identified through the
Stockholm-Gotland Regional Breast Cancer quality register.
Invitations were mailed out in 2009, together with informed
consent documents and a link to an online questionnaire.
The quality and organization of the Stockholm mammog-
raphy screening program has been described in detail previ-
ously by Lind et al. [16]. For our study, only women
diagnosed with incident unilateral invasive breast cancer,
without any other previous cancer with the exception of
non-melanoma skin cancer, without prior breast surgery,
for which mode of detection was available, and who had at
least one pre-diagnostic mammogram and corresponding
PD measurement were included (n = 1403). Our primary
study sample consisted of 394 IC cases and 1009 SC cases.
To try to validate our findings, we analyzed a second
population-based cohort of breast cancer cases, called
‘CAHRES’, which has been described in detail elsewhere
[17]. It contains incident breast cancer cases diagnosed
from October 1, 1993, to March 15, 1995, and reported
to any of the six Swedish Regional Cancer Registries.
The validation sample included 1182 breast cancer cases
(281 IC and 901 SC). The same inclusion and exclusion
criteria were applied as for the primary cohort.
Data collection
The data collection approach has been described in
more detail previously [7]. Information about body mass
index (BMI), hormone replacement therapy (HRT), and
other sociodemographic, anthropometric, hormonal, and
lifestyle factors were obtained through questionnaires
collected during 2009. Use of HRT was classified as ‘yes’
if HRT pills had been used during the year of diagnosis,
and as ‘no’ otherwise. Tumor characteristics were
obtained from linkage with the Stockholm-Gotland
Regional Breast Cancer quality register.
We collected mammograms by contacting local mam-
mography units as well as the national Swedish medical
image repository in Vilhelmina, Sweden. All mammo-
grams were analog film mammograms that were digitized
using an Array 2905HD Laser Film Digitizer, which covers
a range of 0 to 4.7 optical densities. The density resolution
was set at 12-bit dynamic range. The data collection was
performed similarly for the validation cohort.
Image analysis
All analysis was based on digitized film mammograms.
Analysis was based on the last pre-diagnostic mammo-
graphic image per woman, using the mediolateral ob-
lique view of the breast contralateral to the future
tumor. To avoid image acquisition bias related to sus-
pected or diagnosed cancer we did not consider mam-
mograms that were acquired later than 30 days before
diagnosis. PD values were calculated by an automated
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ImageJ-based method developed and validated by Li et al.
in 2012 [18]. This method attempts to mimic the outcome
of the gold standard area-based PD measurement method,
Cumulus [19], and a high correlation (r = 0.884) between
the two methods was demonstrated.
Our aim was to study features of the dense area in the
mammograms, which were obtained by three processing
steps: pre-processing of the image, dense area selection,
and feature extraction. First, the images were pre-
processed by automatically removing nametags and
other artifacts, as well as reducing contrast intensity dif-
ferences between mammograms, and finally by removing
the image area corresponding to the pectoral muscle.
Second, the dense area of the mammogram was auto-
matically identified by a thresholding method. The dense
area thus identified was not necessarily a single continu-
ous area, but could consist of separate parts of the
image. The primary thresholding approach was chosen
to be Otsu’s method [20] for two reasons: it has been
widely used and it was the only specified method used in
the previous two studies of image features and interval
cancer [14, 21]. In addition to Otsu’s method, we used two
alternative thresholding methods: the percentile method
and the entropy of histogram method [22]. Otsu’s method
was based on minimizing the weighted sum of within-
class variances of the foreground and background pixels
to establish an optimum threshold. The percentile method
was based on defining the dense area as all pixels with in-
tensity above the median, i.e., the 50th percentile. The en-
tropy of the histogram method is based on maximizing
the entropy of the histogram, which can be interpreted as
maximum information transfer.
The third step in the image analysis involved the cal-
culation of 32 different features based on the identified
dense area. These were the same features as in a previ-
ous study from our group, which aimed to predict
percent density from statistical features of digital mam-
mograms (using machine learning approaches) [23].
That study showed that a density estimate based on fea-
ture extraction from processed digital mammograms
was associated with breast cancer status, with a similar
amount of evidence as that found for density measures
calculated using another automated method (Volpara)
on raw digital images. In the above-mentioned previous
study, the features were selected to represent various
feature categories. The statistical image features are
based on the intensity value of each pixel, and can be-
long to either first-order or higher-order statistics. First-
order statistics are based on the histogram of all pixels;
examples include median, skewness and kurtosis.
Higher-order statistics take the spatial relationship
between pixels into account; examples include shape
features based on fitting a shape to the silhouette of
the segmented area and texture features based on
measurements of the difference between neighboring
pixels. The features were calculated using the computer
software Matlab [24]. There were only two mammograms
for which the quality did not allow feature calculations;
one interval cancer and one screen-detected cancer.
Statistical analysis
Before performing any statistical tests, we transformed
the feature measures using a Box-Cox transformation
after which they were standardized, in order to attain
near standard normal distributions. We carried out 3 ×
32 tests of association – three tests (the three thresholding
methods described above) for each of the 32 extracted
image features (Table 2). These (Wald) tests were based
on fitting logistic regression models with IC versus SC sta-
tus as the outcome and using continuous PD as an adjust-
ment variable. We performed a global test of association
testing the null hypothesis that none of the features were
associated with IC versus SC status by examining the
number of test results that were significant at the 5 % level
(global test statistic). An empirical (global) level of signifi-
cance was obtained by permuting IC versus SC status over
a large number of simulations (10,000), and calculating
the fraction of (global) test statistic values based on per-
muted data that were larger than the test statistic value
obtained for the non-permuted data set. This global test is
similar to Wilkinson’s test [25] but accounts for the cor-
relation of the features.
To identify individual features, we used a forward se-
lection procedure (the step function in R [26]) based on
our logistic regression model with IC versus SC status as
outcome and with continuous PD, age at diagnosis, BMI
and HRT as covariates. The forward selection was based
on features extracted from the dense area identified by
our primary thresholding approach, Otsu’s method (see
‘Image analysis’). To test for potential confounding by
different length of the time between mammography and
diagnosis for IC and SC, we extended the final model by
adding this as a covariate. The associations between the
identified features and IC versus SC status were assessed
in the validation cohort. Finally, we estimated univariate
linear regression models with tumor size as the outcome
and each feature as the predictor. Since tumor size was
left-skewed we square-root-transformed the variable prior
to analysis. The same analysis was performed within the
SC and the IC subgroups separately. Additionally, regres-
sion models were fitted to examine the association
between each of the identified features and each risk fac-
tor listed in Table 1. All statistical tests were two-sided.
Statistical analyses were carried out in R [26] or Stata [27].
Results
We included 1403 women, 394 IC cases and 1009 SC
cases, in the primary study sample (Table 1). The women
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with IC, compared with SC, had a significantly lower
BMI, higher PD, more often had used HRT during the
year before diagnosis, and more often had a positive
family history of breast cancer. Compared with SC tu-
mors, the IC tumors were larger, had more often lymph
node metastasis, were of a higher Elston grade, and were
Table 1 Patient, mammographic and tumor characteristics (primary study sample)
Study sample (n = 1403)
1C (n = 394)
n (%) or mean
SC (n = 1009)
n (%) or mean
p value Missing data
PATIENT CHARACTERISTICS
Age at diagnosis 60.8 60.2 0.055 0 %
Menopausal at diagnosis 0.150 6.4 %
Yes 297 (81 %) 794 (84 %)
No 71 (19 %) 151 (16 %)
BMI 24.8 25.8 <0.001 3.2 %
HRT use at diagnosis <0.001 5.1 %
No 280 (75 %) 802 (84 %)
Yes 93 (25 %) 156 (16 %)
Oral contraceptive use 0.145 3.1 %
No 78 (21 %) 239 (24 %)
Yes 300 (79 %) 742 (76 %)
Parity
Nulliparous 61 (15 %) 158 (16 %) 0.997 2.2 %
Number of births, parous women 2.13 2.14 0.816 0 %
Age at first birth, parous women 25.7 25.4 0.341 0 %
Family history of breast cancer (first degree) 0.029 7.8 %
No 284 (77 %) 762 (82 %)
Yes 84 (23 %) 162 (18 %)
MAMMOGRAPHIC CHARACTERISTICS
Time (months) from measure to diagnosis 15.3 (median) 24.6 (median) <0.001
Mammographic percent density 23.5 (median) 17.6 (median) <0.001
TUMOR CHARACTERISTICS n (%) or mean n (%) or mean
Tumor size, mm 19.5 15.6 <0.001 7.3 %
Lymph node metastasis <0.001 0.4 %
No 356 (91 %) 960 (96 %)
Yes 37 (9 %) 45 (4 %)
Tumor grade, Elston <0.001 42 %
1 35 (16 %) 147 (25 %)
2 109 (50 %) 323 (54 %)
3 75 (34 %) 127 (21 %)
ER status <0.001 27 %
Negative 57 (19 %) 72 (10 %)
Positive 239 (81 %) 659 (90 %)
PR status 0.002 28 %
Negative 109 (38 %) 201 (28 %)
Positive 181 (62 %) 520 (72 %)
p values for difference between the 1C and SC group were calculated by two-sided t test for continuous variables; and by chi square tests for categorical variables.
See Additional file 1: Table S1 for patient and mammographic data for the validation sample
1C interval breast cancer, SC screen-detected breast cancer, BMI body mass index, HRT hormone replacement therapy, ER estrogen receptor, PR
progesterone receptor
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more often hormone receptor negative. Corresponding
patient and mammographic characteristics for the valid-
ation sample can be found in Additional file 1: Table S1.
Individual p values for the associations between IC
versus SC status and each combination of feature and
dense area selection method are presented in Table 2,
along with a short technical description of each feature.
According to a global test of association we could refute
the null hypothesis that none of the image features are
associated with IC versus SC status with a p value of
0.007. Using a forward selection procedure, features
‘skewness of the intensity gradient’ and ‘eccentricity’ of
Table 2 p values for the association between each feature and IC versus SC, from logistic regression modelling, adjusted for
mammographic percent destiny
p value, n = 1401 (1C: 393, SC: 1008)









Technical feature description - all listed features are based on the identified dense area
F1 0.058 0.069 0.575 DC coefficient of two-dimensional discrete cosine transform
F2 0.636 0.006 0.233 The approximation coefficient of the multilevel discrete two-dimensional wavelet
transform
F3 0.002 0.660 0.006 The max coefficient of the two-dimensional discrete Fourier transform of the local range filter
F4 0.193 0.697 0.037 Kurtosis of the intensity histogram
F5 0.388 0.334 0.053 Skewness of the intensity histogram
F6 0.074 0.026 0.015 Entropy of the intensity histogram
F7 0.282 0.031 0.969 The mean of entropy-filtered selected area
F8 0.467 0.036 0.793 Entropy of the complex imaginary part of the convolved selected area with log-Gabor
filters
F9 0.624 0.045 0.969 Entropy of the complex real part of the convolved selected area with log-Gabor filters
F10 0.582 0.025 0.676 Entropy of the magnitude part of the convolved selected area with log-Gabor filters
F11 0.020 0.148 0.235 The max coefficient of the two-dimensional discrete Fourier transform
F12 0.995 0.026 0.234 Entropy of the normalized co-occurrence matrix
F14 0.600 0.751 0.326 The max coefficient of the two-dimensional discrete Fourier transform of the Hessian
filter
F16 0.058 0.088 0.582 The max coefficient of the log of the magnitude part of the discrete cosine transform
F17 0.020 0.146 0.235 The max coefficient of the log of the magnitude part of the discrete Fourier transform
F18 0.111 0.078 0.443 The fourth central moment
F19 0.012 0.726 0.019 Number of separate blobs
F20 0.312 0.015 0.129 Solidity
F21 0.001 0.970 0.007 Eccentricity
F22 0.966 0.240 0.365 Euler number
F24 <0.001 0.931 0.006 Skewness of the normalized singular value decomposition/its standard deviation
F25 0.040 0.164 0.291 Singular value decomposition
F26 0.062 0.269 0.795 Number of holes within the selected area (low intensity surrounded by high intensity)
F27 0.063 0.026 0.009 Interquartile range of the intensity histogram
F33 0.225 0.317 0.322 Kurtosis of the projection along the Y axis
F34 0.065 0.136 0.201 Kurtosis of the projection along the X axis
F35 0.002 0.211 0.582 Perimeter of the selected area
F37 0.317 0.040 0.415 Mean intensity
F39 0.358 0.168 0.283 Median intensity
F40 0.145 0.012 0.001 Skewness of the intensity gradient
F41 0.172 0.032 0.946 Energy property of the co-occurrence matrix of the selected area - horizontal shift two pixels
F42 0.261 0.031 0.984 Energy property of the co-occurrence matrix of the selected area - diagonal shift eight pixels
p values in bold font signifies that they are below 0.05. Only features based on the dense area of the mammogram were included
1C interval breast cancer, SC screen-detected breast cancer
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the dense area were included in the final model. Eccen-
tricity is calculated by fitting an ellipse to the dense area,
and then taking the ratio of the distance between the
foci of the ellipse and its major axis. Examples of mam-
mograms with high and low ‘skewness of the intensity
gradient’ are presented in Fig. 1, while examples of
mammograms with high and low values of ‘eccentricity’
are presented in Fig. 2.
Table 3 presents the associations of the two image fea-
tures and IC versus SC status in multivariate regression
modelling. In the fully adjusted model, the per-standard
deviation odds ratio (OR) for ‘skewness of the intensity
gradient’ was 1.32 [95 % confidence interval (95 % CI):
1.12 to 1.56] in the primary cohort and 1.21 (95 % CI:
1.04 to 1.41) in the validation cohort, while the corre-
sponding OR for ‘eccentricity’ was 1.20 (95 % CI: 1.04 to
1.39) and 1.17 (0.98 to 1.39). In the primary cohort, the
median time periods between pre-diagnostic mammo-
gram and diagnosis were 24.6 and 15.3 months for screen-
detected and interval cancers respectively. Adjusting the
final regression model for this time period only slightly
changed the estimated odds ratios, and did not affect the
significance of our results. Estimates of the association be-
tween each of the two identified features and the risk fac-
tors in Table 1 can be found in Additional file 2: Table S2.
As shown above, a high ‘skewness of the intensity gra-
dient’ and a high ‘eccentricity’ were both associated with
an increased risk of interval cancer compared with
screen-detected cancer. From fitting linear regression
models with tumor size as the outcome, separately for
SCs and ICs, we found significant evidence that high
‘skewness of the intensity gradient’ of the dense area is
associated with an increased tumor size for SCs, but not
for ICs (Table 4). A high ‘eccentricity’ of the dense area
was significantly associated with a decreased tumor size
for ICs, but not for SCs (Table 4). A high ‘eccentricity’ of
the dense area was significantly associated with a de-
creased tumor size for ICs, but without association with
tumor size for SCs.
Discussion
We identified two novel mammographic features in
screening mammograms of the normal breast that differ-
entiated between future interval cancers and screen-
detected cancers. Since we had no prior hypothesis
about which features should be related to interval can-
cer, we examined a range of statistical and textural fea-
tures used in a previous study [23] by our group. This
set of features is not an exhaustive list of possible fea-
tures to examine; many others have been used in mam-
mographic studies previously [28, 29].
Fig. 1 Feature F40 – ‘skewness of the intensity gradient’. Example of
mammograms in our study which have a similar amount of dense
area but differ in ‘skewness of the intensity gradient’. Our interpretation
is that a high value corresponds to a more consolidated dense area,
and a low value to a more scattered dense area
Fig. 2 Feature F21 – ‘eccentricity’. Example of mammograms in our
study which have a similar amount of total breast area and dense
area but differ in ‘eccentricity’. Our interpretation is that a high value
corresponds to a more elongated overall shape of the dense area,
and a low value to a more circular shape
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We identified two novel image features that were sig-
nificantly different between interval and screen-detected
breast cancers: first, the ‘skewness of the intensity gradi-
ent’, and second, the ‘eccentricity’ of the dense area in
the mammogram. The two features are described in
more technical detail in the Appendix. The p value for
the association between certain features and IC versus
SC status changed markedly depending on which thresh-
olding method was used. This might be interpreted as
either that certain features being more or less robust
than others or that a specific thresholding method is
better suited for calculating certain features. The two
features that we identified were significant for two of
three thresholding methods, and therefore considered to
be quite robust. The first feature, after adjustment for
percent density, was associated with a larger tumor size
at screen detection, and thus related to a reduced mam-
mographic detectability. We speculate that this feature is
a reflection of the extent to which the dense area is
interspersed by fatty streaks, reducing the size that a
tumor must attain before being detectable at screening
mammography. The second feature is related to how
elongated the overall shape of the dense area is. This fea-
ture was associated with the size at interval cancer de-
tection, most of which are detected by palpation. The
mechanism why an elongated shape would promote
early clinical detection is unclear. Speculatively, it might
be related either to less firm normal breast tissue, or to
tumors being located closer to the skin, both of which
would enhance palpability. In Fig. 3, we illustrate how
different combinations of high or low values of these
two features may be manifested in an image.
Several breast cancer screening strategies to reduce the
incidence of IC have been proposed, such as using a sup-
plemental imaging [9], e.g., MRI or ultrasound, which
would be most effective against masked tumors. If
validated in a cohort including healthy women, the two
mammographic features might increase our ability to
individually tailor the breast cancer screening strategy.
Supplemental imaging should potentially be directed to-
ward women with a high percent density and a high value
of our first feature ‘skewness of the intensity gradient’.
Previous studies of associations between interval
breast cancer and image features include Banik et al.
[14] who examined features potentially related to ‘archi-
tectural distortion’. The study was small, (56 interval
cancer cases and 13 screen-detected cases) and did not
take PD into consideration. Another study, by Tan et al.
[21], examined the association between near-term breast
cancer and the difference between image features of the
left versus the right breast mammogram. Neither study
included information about use of HRT, which is an
established IC risk factor [7, 10]. Both studies were
aimed at identifying pre-malignant changes, in principle
Table 3 Associations between identified dense area features and IC versus SC based on multivariate logistic regression modelling
Odds ratios (95 % Cl) for interval versus screen-detected cancer, estimated by logistic regression modelling
Primary cohort Validation cohort
Covariate Model 1 n = 1403 Model 2 n = 1314 Model 3 n = 1312 Model 3 n = 1182
Percent density 1.37 (1.22 to 1.53) 1.23 (1.08 to 1.41) 0.98 (0,81 to 1.17) 1.04 (0.86 to 1.24)
BMI - 0.84 (0.73 to 0.98) 0.88 (0.76 to 1.02) 0.98 (0.84 to 1.15)
HRT use at diagnosis - 1.57 (1.17 to 2.11) 1.53 (1.14 to 2.07) 1.32 (0.99 to 1.77)
Age at diagnosis - 0.98 (0.87 to 1.12) 1.01 (0.89 to 1.15) 0.90 (0.77 to 1.05)
F40 skewness of the intensity gradient - - 1.32 (1.12 to 1.56) 1.21 (1.04 to 1.41)
F21 eccentricity - - 1.20 (1.04 to 1.39) 1.17 (0.98 to 1.39)
Feature values calculated based on the dense area of the mammogram as identified by Otsu's method, then Box-Cox transformed and standardized. Odds ratios
are estimated as per-standard deviation change in the underlying covariate. Validation cohort is an older breast cancer cohort with similar covariate definitions as
the primary cohort
1C interval breast cancer, SC screen-detected breast cancer, 95 % CI 95 % confidence interval, BMI body mass index, HRT hormone replacement therapy
Table 4 Association between each identified feature and the tumor size, stratified by detection mode
Beta coefficient (p value, 95 % confidence interval), estimated by linear regression modelling
Subgroup
Image feature All cancers (n = 1299) Screen-detected (n = 927) Interval cancer (n = 372)
F40 skewness of the intensity gradient 0.16 (p < 0.001, Cl: 0.09 to 0.23) 0.20 (p < 0.001, Cl: 0.12 to 0.29) -0.05 (p = 0.465, Cl: -0.18 to 0.08)
F21 eccentricity 0.021 (p = 0.56S, Cl: -0.050 to 0.091) 0.055 (p = 0.188, Cl: -0.027 to 0.136) -0.18 (p = 0.014, Cl: -0.32 to -0.04)
Tumor size was square-root transformed
Feature values calculated based on the dense area of the mammogram as identified by Otsu's method, then Box-Cox transformed and standardized beta coefficients
represent the mean change in tumor size (measured in mm) per standard deviation change in transformed feature value Cl - 95 % confidence interval. p values in bold
font signifies that they are below 0.05
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masked tumors, while our study was aimed at features of
the normal breast that would impact the risk of IC of any
type: masked, fast-growing or facilitated clinical detection.
One strength of our study is that we were able to use
an independent breast cancer cohort for the validation
of the two features in a fully adjusted model. Another
strength is that we not only examined image features
but also tried alternative methods to select the dense
area. We were also able to adjust for the potential risk
factors PD and HRT, as well as age at mammography
and BMI, with a relatively low degree of missingness. A
potential weakness of our study is that BMI was mea-
sured several years after the analyzed mammographic
images were acquired. This might have affected the (lack
of ) association between BMI and IC versus SC status in
our final model. However, from previous literature there
is no consistent evidence that such an association exists
[30]. A limitation of our study is that we only examined
digitized film mammograms. However, the same feature
algorithms have been used previously for processed
digital images, but for other purposes, and would thus
need to be validated for digital mammograms in relation
to IC versus SC status. The exact values of the features
are the result of pre-processing, dense area selection,
and feature calculation. This entire process was assessed
in two independent cohorts yielding comparable odds
ratios. In future studies aimed at validating our results, it
would be important to perform all three steps according
to our method.
Conclusions
In conclusion, using a novel feature-based approach,
we found two mammographic features of screening
mammograms of the normal breast that differentiated
between future interval cancers and screen-detected
cancers independently of percent density. We present
a starting point for further research into the utility of
image features as a way to identify women at risk of
interval cancer.
Appendix – technical description of identified
features
Feature F21 – ‘eccentricity’
The technical description of Feature 21 is eccentricity.
Eccentricity was calculated by first fitting an ellipse
according to the perimeter of the dense area based on
the second moment method, and then calculating the
ratio between the distance between the foci of the ellipse
and its major axis. A single ellipse was fitted regardless
of whether the dense area was one continuous shape or
consisted of separate parts. Eccentricity is a continuous
measure ranging from 0 to 1. A high eccentricity value
means the ellipse is more elongated, less circular, and a
low eccentricity value means the ellipse is rounder, more
circular. All feature calculations were carried out in
Matlab [24].
Feature F40 – ‘skewness of the intensity gradient’
The technical description of Feature 40 is the skewness
of the intensity gradient. The intensity gradient is the
Fig. 3 Illustration of combinations of the two identified features. Schematic images of four different dense areas with a high versus low value of
‘skewness of the intensity gradient’ and ‘eccentricity’
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change in intensity value between a certain pixel and its
neighboring pixel. All pixels outside the selected dense
area were defined as having zero intensity. The gradient in
our analysis was based only on increases in the horizontal
direction. When calculating the skewness, all non-dense
area pixels are defined as having zero intensity. The largest
gradient is thus achieved at the border between the dense
area and the non-dense area. This gives the gradient value
histogram a bimodal distribution, with the border pixels
corresponding to large gradients and the interior pixels
corresponding to smaller gradients. The intensity gradient
is always skewed since there are more interior pixels than
border pixels. The skewness is increased for a dense area
having a smaller proportion of border pixels compared to
interior pixels. All feature calculations were carried out in
Matlab [24].
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